1. Academic Validation
  2. Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts

Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts

  • Arch Biochem Biophys. 1995 Feb 20;317(1):311-4. doi: 10.1006/abbi.1995.1168.
C N Rao 1 Y Y Liu C L Peavey D T Woodley
Affiliations

Affiliation

  • 1 Department of Dermatology, Northwestern University Medical School, Northwestern University, Chicago, Illinois 60611.
Abstract

Serine proteinase inhibitors play a major role in the turnover of connective tissues. In this study, we isolated and determined partial amino-terminal amino acid sequence of trypsin/Elastase/plasmin inhibitors (M(r) 33,000 and 31,000) from the extracellular matrix of SV40-transformed human skin fibroblasts. The antitrypsin activity of the inhibitors was monitored by substrate reverse zymography. Polyclonal antisera to alpha 1-antitrypsin, alpha 1-antichymotrypsin, alpha 2-antiplasmin, inter-alpha-trypsin inhibitor, plasminogen activator inhibitors-1 and -2, and a monoclonal antibody to protease nexin-1 did not label the 33-, 31-, and 27-kDa inhibitors. A computer search for amino acid sequence homology indicated that the 31-kDa inhibitor is novel. In contrast, the sequence of the 33-kDa inhibitor shared 70 to 90% homology with the amino-terminal sequence of a recently characterized 32-kDa trypsin/tissue factor inhibitor called tissue factor pathway inhibitor-2. The 33- and 31-kDa inhibitors bind to heparin-Sepharose and were recovered from the affinity beads as well as from the t12 FB extracellular matrix with 1 M NaCl. Based on these results, we propose that the extracellular matrix of human mesenchymal cells sequester a family of novel serine proteinase inhibitors.

Figures